Thermo Fisher Scientific Inc. (TMO) operating KPIs
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)
Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%
Thermo Fisher Scientific mảng Transplant Diagnostics (Chẩn đoán ghép tạng HLA One Lambda) ($M)
SEC 10-K / 10-Q Note 6 (Revenue by Business)
Latest, FY2025
492
Period ended Dec 31, 2025
Change on a year earlier
+8.4%
454 in FY2024
History
3 years
Since FY2023
Sources
1
SEC Form 10-K (10k_2025, filed 2026-02-26)
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Mảng Transplant Diagnostics (Chẩn đoán ghép tạng HLA One Lambda) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 492 | +8.4% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 454 | +15.5% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 393 | – | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Mảng Transplant Diagnostics (Chẩn đoán ghép tạng HLA One Lambda) ($M), annual FY2023–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/rev_biz_transplant_diagnostics
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.